Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation : Report from the European EGPA study group
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:79 |
|---|---|
| Enthalten in: |
Allergy - 79(2024), 2 vom: 12. Feb., Seite 516-519 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Caminati, Marco [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal |
|---|
| Anmerkungen: |
Date Completed 01.02.2024 Date Revised 01.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/all.15934 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363966404 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363966404 | ||
| 003 | DE-627 | ||
| 005 | 20240201232000.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/all.15934 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1277.xml |
| 035 | |a (DE-627)NLM363966404 | ||
| 035 | |a (NLM)37904674 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Caminati, Marco |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation |b Report from the European EGPA study group |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.02.2024 | ||
| 500 | |a Date Revised 01.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a EGPA | |
| 650 | 4 | |a T2 inflammation | |
| 650 | 4 | |a benralizumab | |
| 650 | 4 | |a dupilumab | |
| 650 | 4 | |a eosinophilic granulomatosis with polyangiitis | |
| 650 | 4 | |a mepolizumab | |
| 650 | 4 | |a monoclonal antibodies | |
| 650 | 4 | |a omalizumab | |
| 650 | 4 | |a reslizumab | |
| 650 | 4 | |a severe asthma | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 700 | 1 | |a Fassio, Angelo |e verfasserin |4 aut | |
| 700 | 1 | |a Alberici, Federico |e verfasserin |4 aut | |
| 700 | 1 | |a Baldini, Chiara |e verfasserin |4 aut | |
| 700 | 1 | |a Bello, Federica |e verfasserin |4 aut | |
| 700 | 1 | |a Cameli, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Conticini, Edoardo |e verfasserin |4 aut | |
| 700 | 1 | |a Cottin, Vincent |e verfasserin |4 aut | |
| 700 | 1 | |a Crimi, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Dagna, Lorenzo |e verfasserin |4 aut | |
| 700 | 1 | |a Delvino, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Deroux, Alban |e verfasserin |4 aut | |
| 700 | 1 | |a Duran, Emine |e verfasserin |4 aut | |
| 700 | 1 | |a Espigol-Frigole, Georgina |e verfasserin |4 aut | |
| 700 | 1 | |a Karadag, Omer |e verfasserin |4 aut | |
| 700 | 1 | |a Maule, Matteo |e verfasserin |4 aut | |
| 700 | 1 | |a Moiseev, Sergey |e verfasserin |4 aut | |
| 700 | 1 | |a Monti, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Moroni, Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Padoan, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Pugnet, Gregory |e verfasserin |4 aut | |
| 700 | 1 | |a Taille, Camille |e verfasserin |4 aut | |
| 700 | 1 | |a Toniati, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Vaglio, Augusto |e verfasserin |4 aut | |
| 700 | 1 | |a Emmi, Giacomo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Allergy |d 1980 |g 79(2024), 2 vom: 12. Feb., Seite 516-519 |w (DE-627)NLM000313874 |x 1398-9995 |7 nnns |
| 773 | 1 | 8 | |g volume:79 |g year:2024 |g number:2 |g day:12 |g month:02 |g pages:516-519 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/all.15934 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 79 |j 2024 |e 2 |b 12 |c 02 |h 516-519 | ||